Normativa para el asma de control difícil
暂无分享,去创建一个
G. Rodríguez-Trigo | A. López-Viña | E. Martínez-Moragón | A. López-Viña | R. Agüero-Balbín | J. L. Aller-Álvarez | T. Bazús-González | F. B. García-Cosio | A. de Diego-Damiá | E. Martínez-Moragón | A. Pereira-Vega | Plaza-Moral | G. Rodríguez-Trigo | Villa-Asensi | T. Bazús-González | A. Pereira-Vega | F. García-Cosío | A. D. Diego-Damiá | R. Agüero-Balbín
[1] J. Richter,et al. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. , 2000, American journal of respiratory and critical care medicine.
[2] A. Woolcock,et al. Persistent cough: is it asthma? , 1998, Archives of disease in childhood.
[3] A. Woolcock. Corticosteroid-resistant asthma. Definitions. , 1996, American journal of respiratory and critical care medicine.
[4] A. Bush,et al. Safety and ethics of bronchoscopy and endobronchial biopsy in difficult asthma , 2001, Archives of disease in childhood.
[5] D. Geddes,et al. Pseudo-steroid resistant asthma. , 1999, Thorax.
[6] J. Douwes,et al. Non-eosinophilic asthma: importance and possible mechanisms , 2002, Thorax.
[7] I. Adcock,et al. Glucocorticoid suppression of nuclear factor-κB: a role for histone modifications , 2001 .
[8] C. Spielberger,et al. STAI manual for the State-trait anxiety inventory ("self-evaluation questionnaire") , 1970 .
[9] Charles A. Johnson,et al. Pharmacodynamics of omalizumab: implications for optimised dosing strategies and clinical efficacy in the treatment of allergic asthma , 2003, Current medical research and opinion.
[10] R. Martin,et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. , 1998, American journal of respiratory and critical care medicine.
[11] J. Spinelli,et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. , 2000, The Journal of allergy and clinical immunology.
[12] S. Szefler,et al. Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. , 1997, The European respiratory journal.
[13] M. Humbert,et al. Difficult asthma , 2003, Allergy.
[14] Christine Jenkins,et al. GOLD SCIENTIFIC COMMITTEE. GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. NHLBI/WHO GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) WORKSHOP SUMMARY , 2001 .
[15] S. Durham,et al. Systematic assessment of difficult-to-treat asthma , 2003, European Respiratory Journal.
[16] T. Lasserson,et al. Azathioprine as an oral corticosteroid sparing agent for asthma. , 2003, The Cochrane database of systematic reviews.
[17] S. Wenzel,et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.
[18] S. Spector,et al. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.
[19] H. Magnussen,et al. Short term effect of methotrexate in severe steroid-dependent asthma , 2004, Lung.
[20] D. Postma,et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. , 1999, The European respiratory journal.
[21] S. Squillace,et al. Sensitization to dust mites as a dominant risk factor for asthma among adolescents living in central Virginia. Multiple regression analysis of a population-based study. , 1997, American journal of respiratory and critical care medicine.
[22] S. Wenzel,et al. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. , 2002, The American journal of medicine.
[23] J Bousquet,et al. Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE , 2005, Allergy.
[24] D. Postma,et al. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma , 2003, European Respiratory Journal.
[25] D. Solé,et al. METHOTREXATE (MTX) IN THE TREATMENT OF CORTICODEPENDENT ASTHMATIC CHILDREN , 1994, Pediatric Research.
[26] R. Irwin,et al. Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol. , 1993, Chest.
[27] V. Plaza,et al. Costs of asthma according to the degree of severity. , 1998, The European respiratory journal.
[28] C. Bucca,et al. Asthma severity and medical resource utilisation , 2004, European Respiratory Journal.
[29] A. Zwinderman,et al. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. , 2004, American journal of respiratory and critical care medicine.
[30] P. Ernst,et al. Canadian Asthma Consensus Conference Summary of Recommendations , 1996 .
[31] N. Wilson,et al. Evidence for different subgroups of difficult asthma in children , 2001, Thorax.
[32] H. Davies,et al. Methotrexate as a steroid sparing agent for asthma in adults. , 1998, The Cochrane database of systematic reviews.
[33] P. Cullinan,et al. Gold as an oral corticosteroid sparing agent in stable asthma. , 2000, The Cochrane database of systematic reviews.
[34] Y Kikuchi,et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. , 1994, The New England journal of medicine.
[35] F. Ducharme,et al. Inhaled steroids for episodic viral wheeze of childhood. , 2000, The Cochrane database of systematic reviews.
[36] O. Sharma,et al. Parenteral triamcinolone acetonide: an alternative corticosteroid for the treatment of asthma. , 1998, Current opinion in pulmonary medicine.
[37] Ennis,et al. THE ROLE OF COCKROACH ALLERGY AND EXPOSURE TO COCKROACH ALLERGEN IN CAUSING MORBIDITY AMONG INNER-CITY CHILDREN WITH ASTHMA , 2000 .
[38] P. Barnes,et al. Glucocorticoid resistance in asthma. , 1995, American journal of respiratory and critical care medicine.
[39] A. Falus,et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. , 2001, The Journal of allergy and clinical immunology.
[40] S. Mckenzie,et al. What do parents of wheezy children understand by “wheeze”? , 2000, Archives of disease in childhood.
[41] J. Bousquet,et al. Allergic rhinitis and its impact on asthma. , 2001, The Journal of allergy and clinical immunology.
[42] R. Derijk,et al. Glucocorticoid receptor variants: clinical implications , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[43] F. Martinez,et al. Alternaria as a major allergen for asthma in children raised in a desert environment. , 1997, American journal of respiratory and critical care medicine.
[44] R Horne,et al. Compliance in asthma. , 1999, Respiratory medicine.
[45] E. Wahlström,et al. Chlamydia pneumoniae and Severity of Asthma , 2002, Scandinavian journal of infectious diseases.
[46] E. Israel,et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients , 1999, BMJ.
[47] J. Martin,et al. The role of respiratory muscles in the hyperinflation of bronchial asthma. , 2015, The American review of respiratory disease.
[48] P. Cullinan,et al. Cyclosporin as an oral corticosteroid sparing agent in stable asthma. , 2000, The Cochrane database of systematic reviews.
[49] I. Adcock,et al. Glucocorticoid suppression of nuclear factor-kappa B: a role for histone modifications. , 2003, Biochemical Society transactions.
[50] J. Jácome. Guía Española para el Manejo del Asma (GEMA) , 2005 .
[51] S. Wenzel,et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. , 2001, American journal of respiratory and critical care medicine.
[52] R. Strunk. Defining asthma in the preschool-aged child. , 2003, Pediatrics.
[53] I. Adcock,et al. TGFβ1 allele association with asthma severity , 2001, Human Genetics.
[54] A. Bush,et al. Phenotype-specific treatment of difficult asthma in children. , 2004, Paediatric respiratory reviews.
[55] M. H. Williams,et al. High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma. , 1991, The New England journal of medicine.
[56] I. Adcock,et al. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. , 2004, The Journal of allergy and clinical immunology.
[57] J. McNeil,et al. Are asthma medications and management related to deaths from asthma? , 2001, American journal of respiratory and critical care medicine.
[58] M. Rosenthal,et al. The use of cyclosporin in corticosteroid dependent asthma , 1997, Archives of disease in childhood.
[59] I. Adcock,et al. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. , 1998, The Journal of clinical investigation.
[60] I. Adcock,et al. TGFbeta1 allele association with asthma severity. , 2001, Human genetics.
[61] L. Markson,et al. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. , 1999, Respiratory medicine.
[62] E. Gelfand,et al. Histopathology of severe childhood asthma: a case series. , 2003, Chest.
[63] V. Siroux,et al. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. , 2000, The European respiratory journal.
[64] J. Kolbe,et al. Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack , 2000, Thorax.
[65] H. Duivenvoorden,et al. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. , 1985, Journal of psychosomatic research.
[66] B. Johnston,et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol , 2003, Thorax.
[67] C. Corrigan. Asthma refractory to glucocorticoids: The role of newer immunosuppressants , 2002 .
[68] N. Zamel,et al. Unsuspected pseudophysiologic emphysema in chronic persistent asthma. , 2000, American journal of respiratory and critical care medicine.
[69] G. A. Bailey,et al. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. , 1988, The New England journal of medicine.
[70] O. Migita,et al. ADRB2 Polymorphisms and Asthma Susceptibility: Transmission Disequilibrium Test and Meta-Analysis , 2004, International Archives of Allergy and Immunology.
[71] J. Grigg,et al. Intramuscular triamcinolone for difficult asthma , 2005, Pediatric pulmonology.
[72] F. Simons,et al. Montelukast added to budesonide in children with persistent asthma: a randomized, double-blind, crossover study. , 2001, The Journal of pediatrics.
[73] M. Weinberger. Consensus statement from a conference on treatment of viral respiratory infection-induced asthma in young children. , 2003, The Journal of pediatrics.
[74] W. Busse,et al. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. , 1995, American journal of respiratory and critical care medicine.
[75] S. Walker,et al. Anti-IgE for chronic asthma in adults and children. , 2006, The Cochrane database of systematic reviews.
[76] C. Jenkins,et al. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice , 2004, BMJ : British Medical Journal.